Harpoon Therapeutics Inc

Harpoon Therapeutics Inc

HARP

Get informed when a big investor buys or sells

+ Follow
Market Cap$865.08M
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Harpoon Therapeutics IncHarpoon Therapeutics Inc-1.1--687%2.63.2
$24.80

Current Fair Value

7.8% upside

Undervalued by 7.8% based on the discounted cash flow analysis.

Share Statistics

Market cap$865.08 Million
Enterprise Value$861.85 Million
Dividend Yield$- (-)
Earnings per Share$-20.24
Beta1.55
Outstanding Shares3,947,995

Return

Return on Equity-687.27%ROE
Return on Assets-65.60%
Return on Invested Capital-127.25%

Valuation & Multiples

P/E Ratio-1.14P/E Ratio
PEG1.34PEG
Price to Sales2.56Price to Sales
Price to Book Ratio23.01Price to Book Ratio
Enterprise Value to Revenue23.08
Enterprise Value to EBIT-22.98
Enterprise Value to Net Income-28
Total Debt to Enterprise0.02
Debt to Equity3.19Debt to Equity

Revenue Sources

No data

Insider Trades

Institutional Sentiment (Put/Call)

No data available for the latest quarter.

Institutional Ownership

No data available for the latest quarter.

ESG Score

No data

About Harpoon Therapeutics Inc

CEO: Gerald McMahon